November 1, 2022 06:00 AM EDTUpdated November 3, 04:54 AM
Manufacturing

#CPHI22: An­nu­al re­port shows ‘mod­er­ate out­look’ and fo­cus on mR­NA

Tyler Patchen

News Reporter

As the top com­pa­nies and ex­ec­u­tives in the man­u­fac­tur­ing in­dus­try gath­er in Ger­many for the an­nu­al CPHI con­fer­ence, the an­nu­al

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times